Press release
Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Forecast 2025-2034: Evaluating Growth Factors, Segments, and Emerging Trends
Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Segments
The market size of RNA (ribose-nucleic acid)-based therapeutics has experienced a solid increase recently. It's projected to rise from $15.79 billion in 2024 to $17.26 billion in 2025, boasting a compound annual growth rate (CAGR) of 9.3%. The expansion during the previous years can be associated with the escalation of investment and funding, the unveiling of RNA interference (RNAi), clinical triumphs of antisense oligonucleotides (ASOs), supportive regulatory frameworks, and increasing collaborations and partnerships.
Anticipated to witness considerable growth, the ribose-nucleic acid (RNA)-based therapeutics market is set to inflate to $24.26 billion by 2029, exhibiting an 8.9% compound annual growth rate (CAGR). This expected growth during the forecast period can be linked to several factors such as, the broadening of indications, rising market demands and increased adoption, regulatory backing, the incorporation of AI and machine learning and the emergence of applications in rare illnesses. Future trends to watch out for in the given period are advanced delivery systems, RNA therapeutics targeting multiple areas, personalized RNA treatments, regulatory progress, and market growth driven by commercialization.
What Are the Forces Behind the Rapid Growth of the Ribose-Nucleic Acid (RNA)-Based Therapeutics Market?
The rise in cancer cases is anticipated to spur the expansion of the market for ribose-nucleic acid (RNA)-based therapeutics. Cancer is identified by an uncontrollable growth and spread of abnormal cells, which can lead to death if not treated. Aspects like an aging population, lifestyle alterations, higher exposure to hazards, and improved detection techniques contribute to the increasing occurrence of cancer. RNA-based therapeutics present a hopeful option for cancer treatment by directly targeting its genetic and molecular basis. For example, the Australian Institute of Health and Welfare stated in August 2023 that approximately 151,000 individuals were diagnosed with cancer in 2021 (excluding basal cell and squamous cell skin carcinomas), a figure expected to rise to 185,000 by 2030. Thus, the escalating prevalence of cancer is propelling the market for ribose-nucleic acid (RNA)-based therapeutics forward.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18454&type=smp
Which Businesses Are at the Forefront of Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Development?
Major companies operating in the ribose-nucleic acid (RNA)-based therapeutics market are F. Hoffmann-La Roche AG, Eli Lilly and Company, Novo Nordisk A/S, Regeneron Pharmaceuticals, Biogen Inc., Houston Methodist Hospital, BioNTech, University of Oxford, Alnylam Pharmaceuticals, Sarepta Therapeutics, Flagship Pioneering, Ionis Pharmaceuticals, Akcea Therapeutics Inc, Arrowhead Pharmaceuticals, Dicerna Pharmaceuticals, Wave Life Sciences, Pharmaceutical Technology, Quark Pharmaceuticals, Tekmira Pharmaceuticals, ReCode Therapeutics, Arbutus Biopharma Corporation, Benitec Biopharma Inc., Olix Pharmaceuticals, Alltrna Inc., Orbital Therapeutics
What Are the Latest Innovations in the Ribose-Nucleic Acid (RNA)-Based Therapeutics Market?
Major enterprises within the ribose nucleic acid (RNA)-based therapeutics market are dedicated to the creation of novel medicine solutions, including messenger RNA (mRNA)-based booster vaccines. These are designed to boost immunization efficiency, tackle rising viral variants, and reinforce the longevity of vaccine-induced immunity. mRNA based-booster vaccines employ messenger RNA to signal cells to produce a protein that escalates the immune response against specific pathogens. For example, in June 2023, Gennova Biopharmaceuticals Ltd., a pharmaceutical company based in India, introduced GEMCOVAC-OM, the country's first mRNA booster vaccine designed to specifically target the Omicron variant of COVID-19. The necessity for this booster arises due to the diminished effectiveness of the initial vaccines against Omicron. By applying mRNA technology, GEMCOVAC-OM enhances immunity, providing reinforced defense against the mutating virus.
How Is the Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Segmented?
The ribose-nucleic acid (RNA)-based therapeutics market covered in this report is segmented -
1) By Type: RNA Interference (RNAi), RNA Antisense
2) By Technology: Enabling Technology, Enabled Technology
3) By Therapeutic Area: Oncology, Genetic Disorder, Ophthalmology, Hematological Disorders, Acute Hepatic Porphyria (AHP), Other Therapeutic Areas
4) By End User: Research Institutes, Hospitals And Clinics
Subsegments:
1) By RNA Interference (RNAi): Small Interfering RNA (siRNA), MicroRNA (miRNA)
2) By RNA Antisense: Antisense Oligonucleotides (ASOs), Antisense RNA
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/ribose-nucleic-acid-rna-based-therapeutics-global-market-report
Where Is the Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Growth Most Prominent?
North America was the largest region in the ribose-nucleic acid (RNA)-based therapeutics market in 2024. The regions covered in the ribose-nucleic acid (RNA)-based therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Is Covered In The Ribose-Nucleic Acid (RNA)-Based Therapeutics Global Market Report?
- Market Size Analysis: Analyze the Ribose-Nucleic Acid (RNA)-Based Therapeutics Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Ribose-Nucleic Acid (RNA)-Based Therapeutics Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Ribose-Nucleic Acid (RNA)-Based Therapeutics Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Ribose-Nucleic Acid (RNA)-Based Therapeutics Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18454
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Forecast 2025-2034: Evaluating Growth Factors, Segments, and Emerging Trends here
News-ID: 3868710 • Views: …
More Releases from The Business Research Company
Competitive Analysis: Leading Companies and New Entrants in the Wire Arc Additiv …
The wire arc additive manufacturing cell market is rapidly gaining traction as industries increasingly embrace advanced metal 3D printing technologies. With significant investments and technological breakthroughs, this sector is set to experience remarkable growth, transforming manufacturing processes across multiple fields. Let's explore the market's size, influential players, key trends, and segmentation to understand its future trajectory.
Projected Expansion of the Wire Arc Additive Manufacturing Cell Market
The wire arc additive manufacturing cell…
Future Perspectives: Key Trends Shaping the Viscosupplementation Treatment for A …
The viscosupplementation treatment for arthritis market is on the verge of significant expansion, driven by advances in medical technology and a growing demand for effective arthritis therapies. With increasing awareness around early intervention and new treatment options, this sector is poised for rapid development over the coming years. Let's explore the market size, key players, emerging trends, and segment-wise forecasts that define this growing industry.
Projected Market Growth and Size of…
Segmentation, Major Trends, and Competitive Overview of the Viral Vector Develop …
The viral vector development service market is set to experience substantial growth in the coming years, driven by technological progress and increasing demand from various sectors. As gene therapies and advanced treatments gain prominence, the need for efficient viral vector production and development is becoming more critical. Let's explore the market size projections, key players, emerging trends, and the segment structure shaping this industry's future.
Projected Expansion and Market Size of…
Competitive Landscape: Leading Companies and New Entrants in the Transient Elast …
The transient elastography market is poised for substantial expansion as advancements in healthcare diagnostics continue to evolve. Increasing emphasis on non-invasive techniques and early disease detection is driving widespread adoption, setting the stage for strong market growth in the coming years. Let's explore the current market valuation, leading players, emerging innovations, and key segments shaping this industry.
Projected Market Value and Growth of the Transient Elastography Market
The transient elastography market is…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
